SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,592,931 | +24.2% | 87,386 | +17.3% | 0.01% | +33.3% |
Q2 2023 | $8,530,824 | -20.3% | 74,492 | -4.0% | 0.01% | -25.0% |
Q1 2023 | $10,699,330 | +44.2% | 77,627 | +35.5% | 0.01% | +33.3% |
Q4 2022 | $7,421,954 | -65.8% | 57,277 | -70.8% | 0.01% | -64.0% |
Q3 2022 | $21,716,000 | +710.6% | 196,454 | +449.6% | 0.02% | +733.3% |
Q2 2022 | $2,679,000 | -34.3% | 35,746 | -32.6% | 0.00% | -25.0% |
Q1 2022 | $4,078,000 | -92.8% | 53,068 | -91.6% | 0.00% | -92.3% |
Q4 2021 | $56,936,000 | +5739.6% | 632,280 | +5898.9% | 0.05% | +5100.0% |
Q3 2021 | $975,000 | +26.3% | 10,540 | +6.1% | 0.00% | 0.0% |
Q2 2021 | $772,000 | +2.9% | 9,930 | -1.3% | 0.00% | 0.0% |
Q1 2021 | $750,000 | -85.0% | 10,064 | -65.8% | 0.00% | -83.3% |
Q4 2020 | $5,013,000 | +8.5% | 29,406 | -10.6% | 0.01% | 0.0% |
Q3 2020 | $4,621,000 | +155.6% | 32,908 | +191.8% | 0.01% | +200.0% |
Q2 2020 | $1,808,000 | -19.1% | 11,277 | -50.6% | 0.00% | 0.0% |
Q1 2020 | $2,234,000 | +51.0% | 22,848 | +99.3% | 0.00% | 0.0% |
Q4 2019 | $1,479,000 | +67.1% | 11,464 | -2.4% | 0.00% | +100.0% |
Q3 2019 | $885,000 | – | 11,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |